Integrative multi-omics analysis reveals a gut-liver axis signature of metabolic reprogramming associated with response to transarterial chemoembolization in hepatocellular carcinoma

Xiaojing Ren, Zhenyu Liu, Yifan Wang, Peng Guo, Shuyao Cheng, Ruiping Zhang · 2026

Read Integrative multi-omics analysis reveals a gut-liver axis signature of metabolic reprogramming associated with response to transarterial chemoembolization in hepatocellular carcinoma by Xiaojing Ren, Zhenyu Liu, Yifan Wang, Peng Guo, Shuyao Cheng, Ruiping Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13520275.txt.

Description

Xiaojing Ren leads a six-author multi-omics study in 2026 hunting for signals that predict which liver cancer patients respond to chemoembolization, a standard artery-blocking treatment whose benefit varies widely. Stool chemistry was profiled in 30 patients before treatment and four days after, then compared at pathway level with tumor gene data from a separate public cohort.

Treatment shifted stool fats called lysophosphatidylcholines upward, marking acute tissue injury. Responder tumors, meanwhile, ran hotter on bile acid production and tryptophan metabolism, while non-responders favored cell division programs. Ren and colleagues read the overlap as a gut-liver axis signature and propose stool lysophosphatidylcholine as a non-invasive early readout of treatment effect rather than a direct tumor kill marker.

Catalog record

CREATORXiaojing Ren, Zhenyu Liu, Yifan Wang, Peng Guo, Shuyao Cheng, Ruiping Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48306
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13520275

Browse the full library · About the Tower of Babel